Tag: pharmaceuticals
-
Cancer Drug Seen to Reverse Autism Spectrum Symptoms
Small doses of a drug for blood-related cancers are shown in lab mice to reverse social symptoms often found in children with autism spectrum disorder, a condition characterized by limited social activity.
-
What Exactly Is Pharmaceutical Market Access?
Market access is a process which is out in place to ensure that any patient who is appropriate for receiving a certain medicine is able to receive it at a decent price.
-
Evotec Acquiring Sanofi Infectious Disease Portfolio
Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France.
-
Peptide Hydrogel Boosts Cancer Immunotherapies
A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses.
-
Company Formed to Develop Cancer Cell Therapies
The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells.
-
Institute, Company Studying Neuro Disease Proteins
The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments.
-
3-D Biomaterial Boosts Personal Cancer Immunotherapy
A Harvard University bioengineering lab developed an injectable material designed to load up with proteins from a patient’s own tumors to induce immune reactions that fight that person’s cancer.
-
Trial Shows Reduction in Huntington Disease Protein
First results from a clinical trial show an experimental therapy reduces production of a protein damaging nerve cells in people with Huntington disease.
-
Start-Up Developing Blood-Brain Barrier Treatments
A medical school professor in Singapore is starting a biotechnology company to discover and develop new drugs for neurological disorders based on his research with mechanisms for crossing the blood-brain barrier.
-
Biotech Sponsoring Microbiome-Cancer Research
A biotechnology enterprise is starting research collaborations with cancer labs in the U.S. and Germany to study interactions of gut microbes on responses of individuals to cancer immunotherapies.